Compounds > midazolam

midazolam and s 1743

midazolam has been researched along with s 1743 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Backman, JT; Isoherranen, N; Kaartinen, TJK; Launiainen, T; Niemi, M; Tapaninen, T; Tornio, A1
Daali, Y; Desmeules, JA; Lenoir, C; Niederer, A; Rollason, V; Samer, CF1

Other Studies

2 other study(ies) available for midazolam and s 1743

ArticleYear
Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19.
    Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:6

    Topics: Administration, Oral; Caffeine; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Esomeprazole; Female; Healthy Volunteers; Humans; Male; Midazolam; Models, Biological; Pantoprazole; Pharmacogenomic Variants

2020
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.
    CPT: pharmacometrics & systems pharmacology, 2022, Volume: 11, Issue:1

    Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Down-Regulation; Drug Interactions; Esomeprazole; Humans; Inflammation; Interleukin-6; Midazolam; Omeprazole

2022